Free
For trying ProteinIQ
- Free forever
- 3 jobs per day
- Limited atom and residue inputs
- Access to most tools
- Academic license
Prepare targets, screen compounds, dock, and assess ADMET.
Small-molecule discovery is the process of finding and improving low-molecular-weight compounds that can modulate a biological target. A program typically moves from target and compound-library selection through screening, hit confirmation, structure-based design, and early safety or developability review.
ProteinIQ brings the computational parts of that process into one place. You can prepare targets and ligands, screen or generate compounds, inspect docking poses, and compare ADMET signals while retaining the structures, scores, settings, and files behind each result.
Start with a target structure and a compound or library, then choose the workflow that fits the question. ProteinIQ runs the selected methods and keeps their native outputs available for review, export, and the next decision in the discovery loop.
Repair the target, identify plausible pockets, review protonation, and standardize ligand structures before screening.

PDBFixer is an OpenMM-based tool used for fixing problems in protein/DNA/RNA structure files, including adding missing atoms, adding missing residues, and fixing improper formatting.

Open-source protein pocket detection using Voronoi tessellation and alpha spheres. Identifies ligand binding sites with druggability scores.

Predict pKa values of ionizable groups in proteins and protein-ligand complexes from 3D structure. PROPKA calculates environment-driven pKa shifts for standard ionizable residues, terminal groups, and supported ligand atom types.

Fix ligand files that fail RDKit, Meeko, or docking preparation. Repair SDF, MOL, and MOL2 inputs, apply safe chemistry cleanup, and export docking-ready SDF files.

Convert single SMILES strings or small batches into 3D SDF files with downloadable per-entry files and a combined batch output.
Generate pocket-aware candidates and remove compounds with unsuitable properties or structural liabilities before expensive follow-up.

GenMol is a generative AI model from NVIDIA that creates novel drug-like molecules using masked discrete diffusion. It generates molecules in SAFE representation format and supports de novo generation, linker design, motif extension, and scaffold decoration.

PocketFlow is a structure-based molecular generative model that designs novel drug-like molecules within protein binding pockets. It uses autoregressive flow modeling with chemical knowledge to generate 100% chemically valid, highly drug-like compounds.

Compute 200+ RDKit molecular descriptors, drug-likeness rule violations, and structural fingerprints for QSAR, virtual screening, and ML workflows

Lipinski's Rule of Five predicts whether compounds will be orally bioavailable by evaluating molecular weight, LogP, hydrogen bond donors, and acceptors.

Screen compounds for Pan-Assay Interference patterns that cause false positives in biological assays

Screen for lead-like compounds using stricter molecular descriptor criteria than Lipinski or Veber rules for early-stage drug discovery
Use complementary docking methods, preserve their native scores, and check whether proposed complexes are physically plausible.

GNINA is a molecular docking tool that combines traditional physics-based docking with deep learning CNN scoring for protein-small-molecule complexes. It provides accurate binding predictions with confidence scores, optimized for high-throughput virtual screening.

AutoDock Vina predicts protein-ligand binding modes with Vina, Vinardo, or AutoDock4 scoring and returns ranked poses with energy estimates.

DiffDock-L is a state-of-the-art molecular docking tool that uses diffusion models to predict how small molecule ligands bind to protein targets. It generates multiple binding poses with confidence scores.

DynamicBind is an AI-powered protein-ligand binding prediction tool that recovers ligand-induced conformational changes from unbound protein structures. It predicts both ligand binding poses and protein conformational changes.

PoseBusters validates generated or docked molecular poses with chemically and structurally grounded quality checks for molecular geometry, intermolecular interactions, and optional reference-pose agreement.
Review pharmacokinetic and toxicity risk, then apply simulation or free-energy methods to the smaller set that survives triage.

Predict ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties from SMILES strings using machine learning models trained on Therapeutics Data Commons datasets.

Screen compounds for structural toxicity alerts using PAINS, Brenk, and NIH filters. For focused screening, see PAINS Filter, Brenk Filter, or Veber's Rule.

Run GPU-accelerated molecular dynamics simulations using OpenMM. Prepare protein and protein-ligand systems or start from native AMBER topology and restart files.

Calculate binding free energies using MM/PBSA and MM/GBSA methods for protein-ligand, protein-protein, and protein-DNA complexes. Provides detailed energy decomposition and per-residue contributions.

Calculate absolute hydration free energies (AHFE) for neutral small molecules with OpenFE and GPU-accelerated OpenMM simulations.
For trying ProteinIQ
For academics
Everything in Free
For commercial research
Everything in Plus
For organizations at scale
Everything in Pro
ProteinIQ supports small molecule drug discovery workflows for target preparation, ligand preparation, property filtering, docking, ADMET review, toxicity screening, and follow-up structure analysis. You can run the steps as a connected workflow or open the individual upstream tools when you only need one analysis.
ProteinIQ virtual screening tools commonly start from a target structure or model plus ligands in formats such as SMILES, SDF, MOL2, PDB, or tabular compound files. The exact input requirements stay tied to the upstream tool, so docking, filtering, and property prediction steps preserve their native constraints.
Yes. ProteinIQ can help prepare targets and ligands, run filters, dock selected compounds, compare ranked poses, and export a shortlist for review. The platform is designed for computational virtual screening and prioritization, not for silently changing upstream docking scores or replacing experimental follow-up.
ADMET and toxicity prediction in ProteinIQ can be used before docking to reduce a large compound library, after docking to compare top-ranked molecules, or both. These outputs are computational prioritization signals, so ProteinIQ keeps the prediction tables inspectable rather than treating them as experimental validation.
ProteinIQ displays molecular docking results as the upstream tool produces them, including ranked poses, score tables, structure files, logs, and downloadable artifacts where available. The goal is to make docking results easier to compare without changing scoring conventions or hiding the original output files.
Yes. ProteinIQ workflows are useful when you want connected target preparation, ligand filtering, docking, and triage steps, but individual small molecule tools remain available when you only need one analysis. This lets you use ProteinIQ as a workflow layer or as a code-free launcher for a specific upstream tool.
ProteinIQ exports the outputs produced by each small molecule tool, which can include prepared structures, ranked pose files, docking score tables, CSV screening results, logs, and upstream result files. Export support depends on the selected tool, but the platform is built to keep downloadable evidence attached to the compound or target it came from.
No. ProteinIQ helps organize computational screening, molecular docking, ADMET prediction, and toxicity prioritization before experimental follow-up. Experimental binding, ADMET, toxicity, selectivity, and developability assays are still required before making biological or development claims.
You can start in ProteinIQ by choosing a workflow template for docking or screening, or by opening a specific tool such as docking, pocket detection, ADMET prediction, or pose validation. The practical first step is to prepare a target structure and a small ligand set, then expand into larger screening runs after the inputs look correct.